ACTIVE

APOTHEEK BOSEIND

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result265,8 k €-1,6 %over 1 year

Gross margin513,3 k €+3,4 %over 1 year

Equity320,8 k €+0,0 %over 1 year

Workforce2,4 ETP+26,3 %over 1 year

Identity

Source · BCE/KBO

APOTHEEK BOSEIND is a Public limited company incorporated in 2003. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Pelt. It employs on average 2,4 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0479.593.140
Incorporation: 19/02/2003
Legal form: Public limited company
Registered office: Boseind 18
3910 Pelt · FlandreSee on map
Contributed capital: 62 000,00 €
Latest accounts: 31/12/2025
Average workforce: 2,4 ETP

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores 52310Warehousing and support activities for transportation 47740Retail sale of medical and orthopaedic goods in specialised stores 47741Retail sale of medical and orthopaedic goods in specialised stores 47750Retail sale of cosmetic and toilet articles in specialised stores+3

Joint committees (1)

Signals

ProfitableLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 20 filings

Trend over 20 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	513,3 k €	+3.4%	496,6 k €	+31.5%	377,6 k €	+26.2%	299,1 k €	-8.3%	326,1 k €
EBITDA	388,4 k €	+1.4%	382,9 k €	+41.7%	270,2 k €	+37.0%	197,2 k €	-23.8%	258,8 k €
Operating result	330,3 k €	+1.7%	324,7 k €	+53.0%	212,2 k €	+21.3%	174,9 k €	-29.4%	247,8 k €
Net result	265,8 k €	-1.6%	270,1 k €	+39.2%	194,1 k €	-6.2%	206,9 k €	-15.8%	245,7 k €
Balance sheet
Equity	320,8 k €	+0.0%	320,8 k €	+0.0%	320,8 k €	+0.0%	320,7 k €	+71.7%	186,8 k €
Total assets	1,3 M €	+12.2%	1,1 M €	+0.6%	1,1 M €	-26.9%	1,6 M €	+72.9%	903,9 k €
Cash	405,5 k €	+58.1%	256,5 k €	+3.8%	247,1 k €	-51.1%	505,1 k €	+27.5%	396 k €
Debts	961,3 k €	+16.1%	828 k €	+0.8%	821,3 k €	-21.3%	1 M €	+50.7%	692,6 k €
Other
Workforce	2,4 ETP	+26.3%	1,9 ETP	-9.5%	2,1 ETP	-8.7%	2,3 ETP	+53.3%	1,5 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 9 ended

Active mandates

B & V PHARMA

Director · since 19 octobre 2022 · 0877.584.833

Represented by Bart HELEVEN

Active

Ended mandates

B & V PHARMA

Managing director · since 01 janvier 2018 · until 01 janvier 2024 · 0877.584.833

Represented by Bart Heleven

Ended

Marcel Heleven

Director · since 01 janvier 2018 · until 01 janvier 2024

Ended

B & V PHARMA

Managing director · 0877.584.833

Ended

B & V PHARMA

Director · 0877.584.833

Represented by Heleven BART

Ended

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	18/06/2026	10/06/2025	29/08/2024	16/08/2023	31/08/2022	27/08/2021
General meeting	23/05/2026	24/05/2025	25/05/2024	27/05/2023	28/05/2022	22/05/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 20 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	23/05/2026	18/06/2026	Dutch	PDF
Abridged model	31/12/2024	24/05/2025	10/06/2025	Dutch	PDF
Abridged model	31/12/2023	25/05/2024	29/08/2024	Dutch	PDF
Abridged model	31/12/2022	27/05/2023	16/08/2023	Dutch	PDF
Abridged model	31/12/2021	28/05/2022	31/08/2022	Dutch	PDF
Abridged model	31/12/2020	22/05/2021	27/08/2021	Dutch	PDF
Abridged model	31/12/2019	23/05/2020	07/07/2020	Dutch	PDF
Abridged model	31/12/2018	29/06/2019	20/08/2019	Dutch	PDF
Abridged model	31/12/2017	30/06/2018	05/07/2018	Dutch	PDF
Abridged model	31/12/2016	30/06/2017	22/08/2017	Dutch	PDF
Abridged model	31/12/2015	28/05/2016	22/06/2016	Dutch	PDF
Abridged model	31/12/2014	23/05/2015	29/06/2015	Dutch	PDF
Abridged model	31/12/2013	24/05/2014	12/06/2014	Dutch	PDF
Abridged model	31/12/2012	25/05/2013	15/06/2013	Dutch	PDF
Abridged model	31/12/2011	26/05/2012	16/06/2012	Dutch	PDF
Abridged model	31/12/2010	28/05/2011	08/06/2011	Dutch	PDF
Abridged model	31/12/2009	22/05/2010	29/05/2010	Dutch	PDF
Abridged model	31/12/2008	23/05/2009	06/06/2009	Dutch	PDF
Abridged model	31/12/2007	23/05/2008	29/05/2008	Dutch	PDF
Abridged model	31/12/2006	26/05/2007	01/06/2007	Dutch	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 9 ended

Active mandates

B & V PHARMA

Director · since 19 octobre 2022 · 0877.584.833

Represented by Bart HELEVEN

Active

Ended mandates

B & V PHARMA

Managing director · since 01 janvier 2018 · until 01 janvier 2024 · 0877.584.833

Represented by Bart Heleven

Ended

Marcel Heleven

Director · since 01 janvier 2018 · until 01 janvier 2024

Ended

B & V PHARMA

Managing director · 0877.584.833

Ended

B & V PHARMA

Director · 0877.584.833

Represented by Heleven BART

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates26/01/2023
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - BENAMING - ONTSLAGEN - BENOEMINGEN
PDF
Mandates14/09/2018
ONTSLAGEN - BENOEMINGEN
PDF
Mandates08/06/2012
ONTSLAGEN - BENOEMINGEN
PDF
Mandates24/04/2006
ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING - KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Mandates07/03/2006
ONTSLAGEN - BENOEMINGEN
PDF
Mandates23/10/2003
ONTSLAGEN - BENOEMINGEN
PDF
Other27/02/2003
RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

2025
Annual accounts 2025265,8 k €↓
2024
Annual accounts 2024270,1 k €↑
2023
Annual accounts 2023194,1 k €↓
2022
Annual accounts 2022206,9 k €↓
2022
Name changeAPOTHEEK BOSEIND
2021
Annual accounts 2021245,7 k €↑
2020
Annual accounts 2020235,4 k €↓
2019
Annual accounts 2019243,8 k €↑
2018
Annual accounts 2018193,8 k €↑
2017
Annual accounts 2017182,6 k €↓
2016
Annual accounts 2016193,9 k €↑
2015
Annual accounts 2015188,8 k €↑
2014
Annual accounts 2014151,6 k €↓
2013
Annual accounts 2013163,2 k €↑
2012
Annual accounts 201278,2 k €↑
2011
Annual accounts 201168,6 k €↑
2010
Annual accounts 201042,1 k €↓
2009
Annual accounts 200942,7 k €↓
2008
Annual accounts 200886,9 k €↑
2007
Annual accounts 200739,5 k €↑
2006
Annual accounts 200635,3 k €
2006
Name changeApotheek Van Moll
19/02/2003
IncorporationPublic limited company

APOTHEEK BOSEIND

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline